EPIDUO (adapalene and benzoyl peroxide) by Galderma is protein. First approved in 2008.
Drug data last refreshed 10m ago · AI intelligence enriched 1w ago
EPIDUO is a topical gel combining adapalene (a retinoid modulator of cellular differentiation and keratinization) and benzoyl peroxide (an oxidizing antibacterial agent) approved for acne treatment. The combination addresses inflammatory processes and bacterial colonization simultaneously through complementary mechanisms. It represents a fixed-dose combination strategy in dermatology.
Product faces loss of exclusivity in July 2027 (1.1 years remaining); commercial teams should prioritize lifecycle extension strategies and brand loyalty initiatives before generic erosion.
protein. Biochemical and pharmacological profile studies have demonstrated that adapalene is a modulator of cellular differentiation, keratinization and inflammatory processes. However, the significance of these findings with regard to the mechanism of action of adapalene for the treatment of acne…
Retinoid
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel
Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne
Long-term Study of Epiduo in Patients With Moderate to Severe Acne
Effect of Samples on Acne Treatment With Epiduo® Gel
Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne
Worked on EPIDUO at Galderma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moPatent cliff in ~2 years — expect lifecycle management and generic defense hiring
Working on EPIDUO offers exposure to dermatology commercial strategy and topical formulation marketing, but the imminent LOE significantly constrains long-term career growth within this brand. Professionals should view this as a transitional role unless willing to lead cost-optimization and generic competition strategies.